Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 100 Total
AVD - American Vanguard Corp. - Stock Price Chart
TickerAVD [NYSE, RUT]
CompanyAmerican Vanguard Corp.
CountryUSA
IndustryAgricultural Inputs
Market Cap245.10MEPS (ttm)0.25
P/E35.15EPS this Y125.00%
Forward P/E9.37EPS next Y59.83%
PEG-EPS past 5Y-20.02%
P/S0.42EPS next 5Y-1.00%
P/B0.68EPS Q/Q-16.36%
Dividend1.37%Sales Q/Q8.21%
Insider Own6.72%Inst Own81.72%
Insider Trans1.44%Inst Trans-4.28%
Short Float3.62%EarningsMay 09/a
Analyst Recom1.00Target Price18.00
Avg Volume203.83K52W Range8.41 - 18.38
American Vanguard Corp. is a holding company which engages in the development and marketing of specialty and agricultural products for crop protection and management, turf and ornamentals management, public and animal health. It also acquires and licenses both new and well-established product lines that serve numerous market niches. The company was founded by Herbert A. Kraft and Glenn A. Wintemute in January 1969 and is headquartered in Newport Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Macicek Steven DDirectorMay 15 '24Buy9.018,50076,62410,044May 17 06:26 AM
Trogele UlrichSee RemarksDec 14 '23Buy10.725,00053,625191,676Dec 14 08:30 PM
Trogele UlrichSee RemarksDec 11 '23Buy10.052,48825,004186,676Dec 12 02:13 PM
Trogele UlrichSee RemarksDec 07 '23Buy9.975,01550,000184,188Dec 12 02:09 PM
ROSENBLOOM KEITH MDirectorNov 21 '23Buy9.055,70051,579974,155Nov 22 04:18 PM
AVXL - Anavex Life Sciences Corporation - Stock Price Chart
TickerAVXL [NASD, RUT]
CompanyAnavex Life Sciences Corporation
CountryUSA
IndustryBiotechnology
Market Cap380.88MEPS (ttm)-0.50
P/E-EPS this Y13.33%
Forward P/E-EPS next Y-23.08%
PEG-EPS past 5Y-9.03%
P/S-EPS next 5Y-
P/B2.78EPS Q/Q23.60%
Dividend-Sales Q/Q-
Insider Own3.16%Inst Own37.85%
Insider Trans-2.49%Inst Trans-1.98%
Short Float25.97%EarningsMay 09/b
Analyst Recom1.00Target Price27.50
Avg Volume1.29M52W Range3.25 - 10.45
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thomas SteffenDirectorMay 15 '24Buy4.525,00022,6005,000May 17 06:01 AM
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Option Exercise1.3273,38096,8621,323,590Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Sale5.1173,380374,9721,250,210Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 29 '23Option Exercise1.60232,000371,2001,250,210Jun 30 08:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 28 '23Option Exercise1.60268,000428,8001,286,210Jun 30 08:00 PM
ALTI - AlTi Global Inc - Stock Price Chart
TickerALTI [NASD, RUT]
CompanyAlTi Global Inc
CountryUSA
IndustryAsset Management
Market Cap326.42MEPS (ttm)-1.52
P/E-EPS this Y110.81%
Forward P/E8.99EPS next Y68.42%
PEG-EPS past 5Y-
P/S1.34EPS next 5Y-
P/B0.82EPS Q/Q120.38%
Dividend-Sales Q/Q-12.46%
Insider Own53.38%Inst Own9.13%
Insider Trans0.27%Inst Trans0.10%
Short Float2.26%EarningsMay 10/b
Analyst Recom1.00Target Price9.00
Avg Volume139.93K52W Range4.07 - 9.22
AlTi Global, Inc. is a financial services company, which engages in the provision of investment, advisory, and administrative services. The company was founded on December 18, 2020 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keaney Timothy FPresident, Asset ManagementMay 16 '24Buy4.6016,41775,51897,321May 16 09:34 PM
Keaney Timothy FPresident, Asset ManagementMay 15 '24Buy4.5250,195226,88180,904May 16 09:34 PM
Keaney Timothy FPresident, Asset ManagementMay 14 '24Buy4.6217,59881,30330,709May 16 09:34 PM
Moran Kevin P.See RemarksMay 14 '24Sale4.705912,778175,184May 16 05:03 PM
ilWaddi Cayman Holdings10% OwnerApr 03 '24Buy4.9920,00099,80017,933,265Apr 04 04:15 PM
AQMS - Aqua Metals Inc - Stock Price Chart
TickerAQMS [NASD]
CompanyAqua Metals Inc
CountryUSA
IndustryWaste Management
Market Cap49.49MEPS (ttm)-0.25
P/E-EPS this Y2.50%
Forward P/E-EPS next Y48.72%
PEG-EPS past 5Y26.38%
P/S1649.79EPS next 5Y35.00%
P/B2.16EPS Q/Q7.76%
Dividend-Sales Q/Q-
Insider Own4.69%Inst Own19.34%
Insider Trans11.97%Inst Trans1.12%
Short Float3.42%EarningsMay 15/a
Analyst Recom1.00Target Price3.00
Avg Volume489.87K52W Range0.37 - 1.76
Aqua Metals, Inc. engages in reinventing metal recycling technologies. Its patented technology, AquaRefining, replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover valuable metals and materials from spent batteries with higher purity, lower emissions, and minimal waste. The company was founded by Stephen R. Clarke, Thomas Murphy, and Selwyn Mould on June 20, 2014 and is headquartered in Reno, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cotton StephenChief Executive OfficerMay 14 '24Buy0.39250,00097,5006,352,233May 16 08:11 PM
YI SUNGDirectorMay 14 '24Buy0.3975,00029,250105,500May 16 09:33 PM
DIVITO VINCENT LDirectorMay 14 '24Buy0.3962,50024,375421,698May 16 08:18 PM
Zhang PeifangDirectorMay 14 '24Buy0.3962,50024,375313,550May 16 08:20 PM
Merrill JuddChief Financial OfficerMay 14 '24Buy0.3937,50014,6252,076,416May 16 08:12 PM
IZEA - IZEA Worldwide Inc - Stock Price Chart
TickerIZEA [NASD]
CompanyIZEA Worldwide Inc
CountryUSA
IndustryInternet Content & Information
Market Cap51.55MEPS (ttm)-0.49
P/E-EPS this Y37.78%
Forward P/E-EPS next Y92.86%
PEG-EPS past 5Y30.03%
P/S1.50EPS next 5Y10.00%
P/B0.81EPS Q/Q-11.23%
Dividend-Sales Q/Q-20.43%
Insider Own17.16%Inst Own15.55%
Insider Trans81.43%Inst Trans-15.62%
Short Float0.87%EarningsMay 15/a
Analyst Recom1.00Target Price8.75
Avg Volume87.65K52W Range1.83 - 3.60
IZEA Worldwide, Inc. engages in the creation and operation of online marketplaces that connect marketers with content creators under IZEAx platform. It automates influencer marketing and custom content development, which allows brands and agencies to scale their marketing programs. The company was founded by Edward Hans Murphy in February 2006 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GP Investments, Ltd.10% OwnerMay 16 '24Buy2.77178,330493,9743,002,036May 16 08:45 PM
GP Investments, Ltd.10% OwnerMay 14 '24Buy3.20928,1142,969,9652,823,706May 16 08:45 PM
GP Investments, Ltd.10% OwnerMay 10 '24Buy3.141023201,895,592May 13 06:33 PM
GP Investments, Ltd.10% OwnerMay 09 '24Buy3.0638,021116,3441,895,490May 13 06:33 PM
GP Investments, Ltd.10% OwnerMay 03 '24Buy3.001,4274,2811,857,469May 03 06:21 PM
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD, RUT]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap242.26MEPS (ttm)-0.57
P/E-EPS this Y-68.86%
Forward P/E-EPS next Y33.80%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q0.83%
Dividend-Sales Q/Q-
Insider Own29.67%Inst Own51.29%
Insider Trans-29.54%Inst Trans2.15%
Short Float22.90%EarningsMay 10/b
Analyst Recom1.80Target Price4.40
Avg Volume778.31K52W Range1.12 - 13.51
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.SVP of Regulatory DevelopmentApr 22 '24Sale2.5116,43841,315155,194Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 18 '24Sale2.548002,028171,632Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 16 '24Sale2.5017,23843,095172,432Apr 17 06:57 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 12 '24Sale1.7384,103145,498189,670Apr 16 04:54 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 01 '24Sale1.69300507273,773Apr 16 04:54 PM
BKTI - BK Technologies Corp - Stock Price Chart
TickerBKTI [AMEX]
CompanyBK Technologies Corp
CountryUSA
IndustryCommunication Equipment
Market Cap48.75MEPS (ttm)-0.09
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-55.14%
P/S0.66EPS next 5Y22.50%
P/B2.27EPS Q/Q151.26%
Dividend-Sales Q/Q-2.62%
Insider Own18.40%Inst Own40.89%
Insider Trans-0.88%Inst Trans-8.38%
Short Float0.06%EarningsMay 09/b
Analyst Recom1.00Target Price20.00
Avg Volume26.58K52W Range8.79 - 16.85
BK Technologies Corp. is a holding company, which engages in the provision of two-way radio communications equipment. It offers product to the fire, EMS, police, federal, and municipalities agencies. The company was founded on October 24, 1997 and is headquartered in West Melbourne, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Horowitz JoshuaDirectorMay 16 '24Buy13.778,169112,46280,809May 16 08:07 PM
Horowitz JoshuaDirectorMay 15 '24Buy13.455,57274,95372,640May 16 08:07 PM
Horowitz JoshuaDirectorMay 14 '24Buy13.232,89338,28067,068May 16 08:07 PM
Fundamental Global GP, LLC10% OwnerJan 30 '24Sale12.297,05386,681248,975Jan 31 07:22 PM
Fundamental Global GP, LLC10% OwnerJan 29 '24Sale12.4913,906173,686256,028Jan 31 07:22 PM
XGN - Exagen Inc - Stock Price Chart
TickerXGN [NASD]
CompanyExagen Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap32.83MEPS (ttm)-1.09
P/E-EPS this Y10.61%
Forward P/E-EPS next Y23.55%
PEG-EPS past 5Y2.69%
P/S0.59EPS next 5Y-
P/B1.64EPS Q/Q57.32%
Dividend-Sales Q/Q28.36%
Insider Own25.01%Inst Own35.78%
Insider Trans0.48%Inst Trans-0.83%
Short Float0.03%EarningsMay 13/b
Analyst Recom1.33Target Price5.50
Avg Volume45.33K52W Range1.30 - 3.92
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ABALLI JOHNPresident and CEOMay 16 '24Buy1.9240,40177,57040,401May 16 08:02 PM
Adawi KamalCFO and Corporate SecretaryMar 04 '24Sale1.9112,78424,407243,749Mar 06 04:05 PM
Adawi KamalCFO and Corporate SecretaryFeb 06 '24Sale1.956,73813,133181,533Feb 08 04:05 PM
ABALLI JOHNPresident and CEOOct 17 '23Sale1.7533,81959,018415,984Oct 18 04:05 PM
TULLIS JAMES L L10% OwnerJun 15 '23Buy3.111675191,515,839Jun 20 05:04 PM
AMLX - Amylyx Pharmaceuticals Inc - Stock Price Chart
TickerAMLX [NASD, RUT]
CompanyAmylyx Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap124.46MEPS (ttm)-1.07
P/E-EPS this Y-508.33%
Forward P/E-EPS next Y49.68%
PEG-EPS past 5Y-
P/S0.31EPS next 5Y-
P/B0.38EPS Q/Q-7986.04%
Dividend-Sales Q/Q24.10%
Insider Own30.26%Inst Own71.45%
Insider Trans-0.16%Inst Trans32.39%
Short Float17.96%EarningsMay 09/b
Analyst Recom2.71Target Price4.08
Avg Volume3.54M52W Range1.70 - 28.13
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Quimi DaphneDirectorMay 15 '24Buy1.892,2504,2525,000May 16 07:37 PM
Mazzariello GinaChief Legal OfficerMay 15 '24Sale1.8810,45519,654151,477May 16 07:36 PM
Quimi DaphneDirectorMay 14 '24Buy1.892,7505,1842,750May 16 07:37 PM
Klee Justin B.Co-Chief Executive OfficerMar 05 '24Sale18.734,13577,4402,959,308Mar 07 04:05 PM
Cohen Joshua BCo-Chief Executive OfficerMar 05 '24Sale18.734,13577,4403,023,002Mar 07 04:05 PM
HEAR - Turtle Beach Corp - Stock Price Chart
TickerHEAR [NASD, RUT]
CompanyTurtle Beach Corp
CountryUSA
IndustryConsumer Electronics
Market Cap343.03MEPS (ttm)-0.66
P/E-EPS this Y259.20%
Forward P/E11.13EPS next Y38.33%
PEG-EPS past 5Y-
P/S1.31EPS next 5Y16.00%
P/B2.69EPS Q/Q101.98%
Dividend-Sales Q/Q8.56%
Insider Own32.61%Inst Own62.82%
Insider Trans0.24%Inst Trans-9.68%
Short Float3.21%EarningsMay 07/a
Analyst Recom1.33Target Price22.20
Avg Volume402.81K52W Range7.97 - 18.45
Turtle Beach Corp. engages in the development, commercialization, and marketing of audio peripherals. The firm provides gaming accessory. The company was founded by Elwood G. Norris and James A. Barnes in 1975 and is headquartered in White Plains, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jimenez TerryDirectorMay 14 '24Buy16.372,02533,14940,909May 16 07:23 PM
Jimenez TerryDirectorMay 09 '24Buy16.252,02532,90638,884May 13 05:27 PM
Scherping Katherine LeeDirectorJun 05 '23Buy10.755005,37515,857Jun 06 04:05 PM
Scherping Katherine LeeDirectorJun 02 '23Buy11.005005,50015,357Jun 06 04:05 PM
Jimenez TerryDirectorMay 19 '23Buy11.592,50028,97526,551May 22 06:11 PM
12345678910